Fraud and Misconduct in Clinical Research

Principles and Practice of Pharmaceutical Medicine, Second Edition

Volumn , Issue , 2007, Pages 631-641

  Barrett, Jane ^a  

^a NONE   (United Kingdom)

Author keywords

Contract Research Organization (CRO); Fraud and misconduct in clinical research; Plagiarism; Research Governance Framework for Health and Social Care; Research misconduct and scientific objectivity

Indexed keywords

EID: 84889400210     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470093153.ch49     Document Type: Chapter

References (19)

1. Ankier S. 2004. Misconduct and fraud in clinical research. In Medical Law and Research. Ankier Associates.
2. Code of Good Practice in Research: a document for all staff and students undertaking research. (undated). University of Abertay Dundee. cserv.tay.ac.uk/.../Procedural%20documents/Abertay%20Code% 20of%20Good%20Research%20Practice.doc Accessed 30/12/2004.
3. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal, 01/05/2001.
4. Eaton L. 2004. A quarter of UK students are guilty of plagiarism, survey shows. BMJ 329: 70.
5. Edwards D. Whistleblower. In Fraud and Misconduct in Biomedical Research, Lock, Wells, Farthing (eds), 3rd ed. BMJ Books.
6. Eichenwald K, Kolata G. A Doctor's Drug Studies Turn Into Fraud. New York Times, May 17, 1999.
7. Evans S. 2001. Statistical aspects of the detection of fraud. In Fraud and Misconduct in Biomedical Research, Lock, Wells, Farthing (eds), 3rd ed. BMJ Books.
8. Fabrication, falsification, plagiarism, or other practices that seriously deviate from those that are commonly accepted within the scientific community for proposing, conducting, or reporting research' (42 CFR 50.102).
9. Farthing MJG. 2004. 'Publish, and be damned...' The road to research misconduct. J. R. Coll. Physicians Edinb. 34: 301-304.
10. http://ori.hhs.gov/misconduct/ori_summary_angelides. shtml, accessed 6/1/2005.
11. http://www.wellcome.ac.uk/doc%5Fwtd002756.html, acces"sed 30/12/2004.
12. Humphrey GF. 1994. Scientific fraud: the McBride case-judgment. Med. Sci. Law 34(4): 299-306.
13. In the UK the Public Interest Disclosure Act, 1988.
14. Mayor S. 2000. New governance framework for NHS research aims to stop fraud. BMJ 321: 725.
15. McBride WG, Vardy PH, French J. 1982. Effects of scopolamine hydrobromide on the development of the chick and rabbit embryo. Aust. J. Biol. Sci. 35(2): 173-178.
16. McBride WG. 1961. Thalidomide and congenital abnormalities. Lancet 2: 1358.
17. Sheikh A. 2000. Publication ethics and the research assessment exercise: reflections on the troubled question of authorship. J. Med. Ethics 26: 422-426.
18. Stonier P, Lowe GDO, McInnes G, Murie J, Petrie J, Wells F. 2001. A national panel for research integrity: a proposed blueprint for the prevention and investigation of misconduct in biomedical research. Proc. R. Coll. Physicians Edinb. 31: 253-255.
19. Supplement 7: Joint Consensus Conference on Misconduct in Biomedical Research, Edinburgh Royal College of Physicians; 2000.